Search

everythinglearnresearchcommunity

for

Search:↓

New genetic locations explain much of hair color variation in Europeans.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Longer CAG repeats in gene linked to more severe hair loss in females.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Hair loss gene found on chromosome 3q26.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

AR polyglycine repeat doesn't cause baldness.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Passiflora incarnata may help with anxiety but has risks and drug interactions. There's a genetic link between Fragile X Syndrome and Autism Spectrum Disorder. 6.7% of urine cultures showed hospital-acquired urinary tract infections. Children used screens more during COVID-19, causing various health complaints. Autism Spectrum Disorder is often underdiagnosed in females. Dissociative disorders in childhood sexual abuse victims are more common in males. Most pregnant teenagers are not dissatisfied with their body image but worry about weight. Diagnosing tuberculosis after knee surgery is challenging due to non-specific symptoms. Post-COVID-19 syndrome is more common in older, severely affected patients. Psychiatrists should be part of pain management teams due to the psychological aspects of pain.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Certain gene variations are linked to better memory in healthy Chinese women.

Women with hair loss have more androgen receptors in certain hair follicles.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Mutations in certain receptors can cause diseases and offer new treatment options.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Finasteride side effects in young men may be linked to specific gene variations.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.